Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Prolaio
- Study ID
- NCT05678530
- Status
- Recruiting
Conditions
- Cardiopulmonary
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
In this study, the hypothesis being explored is that peak VO2 and potentially other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using FDA-cleared wearable biosensors worn by study participants. This study will aim to collect data using wearable biosensors from standard of care patients toward the development of an algorithm that can estimate peak VO2 (eVO2peak) from biosensor data. In addition, this study will explore to further develop other estimated measurements typically reported in CPET, such as VE/VCO2 slope, as well as selected and measures of Left Ventricular Function (diastolic and systolic) typically reported in echocardiogram; instead using wearable biosensors from standard of care testing. A total of 2000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 1900 participants.
Key Dates
- First listed
- Jan 10, 2023
- Start date
- Jun 6, 2019
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: HealthyHealthy Subjects who undergo the CPET, or an ECHO, or both CPET and ECHO, as part of routine Standard of Care
- Arm: Standard of CareStandard of Care subjects who undergo the CPET, or an ECHO, or both CPET and ECHO, as part of routine Standard of Care
Primary Outcome Measure
Collect development and validation data for a peak VO2 (eVO2peak) machine learning algorithm and to evaluate the performance of the algorithm. [ Time Frame: From enrollment to the end of collection at 7 days ]
Central Contacts
- Clinical Trials at Prolaio855-869-9054
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | Arizona | 85259 | Courtney Wheatley-Guy, PhD (PRINCIPAL_INVESTIGATOR) |
| VA Palo Alto Healthcare System | Palo Alto | California | 94304 | Jonathan Myers, PhD (PRINCIPAL_INVESTIGATOR) |
| University of California San Francisco | San Francisco | California | 94143 | Theodore Abraham, MD (PRINCIPAL_INVESTIGATOR) |
| The Lundquist Institute | Torrance | California | 90502 | Study Coordinator William Stringer, MD (PRINCIPAL_INVESTIGATOR) |
| Nemours Cardiac Center | Wilmington | Delaware | 19803 | Takeshi Tsuda, MD (PRINCIPAL_INVESTIGATOR) |
| Memorial Healthcare System, Office of Human Research | Hollywood | Florida | 33021 | Iani Patsias, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Bryan J. Taylor, PhD (PRINCIPAL_INVESTIGATOR) |
| New Generation of Medical Research | Naples | Florida | 34116 | - |
| physIQ | Chicago | Illinois | 60606 | - |
| University of Illinois Hospital & Health Sciences System | Chicago | Illinois | 60608 | - |
| Advocate Aurora Health Institute | Oakbrook Terrace | Illinois | 60181 | - |
| Mayo Clinic | Rochester | Minnesota | 55905 | Thomas P. Olson, PhD (PRINCIPAL_INVESTIGATOR) |
| Baylor Scott & White Research Institute | Dallas | Texas | 75246 | Mark Millard, MD (PRINCIPAL_INVESTIGATOR) |
| Baylor Scott & White The Heart Hospital - Plano | Plano | Texas | 75093 | Aasim M. Afzal, MD (PRINCIPAL_INVESTIGATOR) |
| Intermountain Medical Center | Murray | Utah | 84107 | Matthew J. Hegewald, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- Lung and Heart Function Across Decades of Life in HealthRecruiting · University of California, San Francisco · San Francisco, California
- COMPARE-VENT Feasibility Pilot StudyRecruiting · Mayo Clinic · Rochester, Minnesota
- Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care PathwaysEnrolling By Invitation · Peerbridge Health, Inc · Pasadena, California
- Triple EIT (Electrical Impedance Tomography)Recruiting · University of Colorado, Denver · Aurora, Colorado